David Ellerton elected NOAH chairman for 2014
David Ellerton has been elected as Chairman of NOAH (National Office of Animal Health) for 2014, following this year’s NOAH AGM in London on 15 May. David is Managing Director of Virbac Ltd. A member of the NOAH Board since 2005, David served as Treasurer for three years, before becoming Vice-Chairman.
Commenting, he thanked the staff and Officer team at NOAH for their work over the last year and set out his priorities for the year ahead: “For a start, we look to Europe as we await publication of the draft revision to the Directive of the European Veterinary Medicines legislation,” he explained. “The new rules may come in the form of a Regulation, rather than a Directive, meaning they are applied ‘straight from the box’ across each member state. We believe this to be an opportunity and are eager to get the ball rolling.
“Antimicrobial resistance is also a priority,” he went on. “Last year, NOAH, together with RUMA, the NFU and the Alliance to Save Our Antibiotics, gave evidence at an enquiry into Antimicrobial Resistance undertaken by The House of Commons Select Committee on Science and Technology. We await its findings with interest.
“Supporting our members is a third area of focus,” said Mr Ellerton. “Initiatives such as the NOAH Certificate of Animal Health (NCAH) give our field staff a thorough grounding in animal physiology, animal disease and treatment options, as well as a full knowledge of the legal framework in which medicines are regulated, advertised and sold. We need to spread the word about the NCAH – it is something we should be proud of and that our customers should be aware of.”
He concluded: “Finally, we must work together to build understanding of the role of animal medicines. There is still a huge opportunity to grow the number of animals benefitting from medicines. If we can develop strategies to deliver this growth, not only will we help our members and our colleagues in the veterinary profession, but we will also increase animal welfare and enable owners to enjoy the companionship of their pets for longer. There is much to do but the opportunity is great and I am honoured to serve NOAH as its Chairman at such an exciting time.”
Notes for Editors
The National Office of Animal Health represents the UK animal medicines industry: its aim is to promote the benefits of safe, effective, quality medicines for the health and welfare of all animals.
Having left Agricultural College David Ellerton started his business career as a depot manager in north Wales for an animal health merchant. After several years, the lure of a manufacturer called and he joined Grampian Pharmaceuticals, initially as a sales representative, before becoming marketing manager. In 1997 he accepted a role with Animalcare, to develop their licensed pharmaceutical business. In 2002 he became General Manager of EVS, before being recruited in 2004 by his previous MD at Grampian, into his current role as Managing Director of Virbac Ltd. In this position David is directly responsible for the UK and Ireland, and is heavily involved in defining their European Strategy through the Group European Committee.
He began his career at NOAH 20 years ago on its Companion Animal Sub-Committee. He has also served on the Public Affairs Committee and was the NOAH appointed director to AMTRA (Animal Medicines training regulatory Authority). A NOAH Board member since 2005, he was NOAH treasurer from 2009-2012, when he became vice-chairman.
Founded by a veterinary surgeon, Virbac is dedicated to supporting the veterinary profession through the development of innovative products and services, which help animals to lead longer, healthier lives. One of the largest independent veterinary pharmaceutical companies in the world, its wide product portfolio includes many market-leading and award-winning products for large and small animals.
The NOAH Officers for 2014-2015 are:
Chairman David Ellerton, Virbac
Treasurer Ferenc Polz, Bayer
Past Chairman John Hanley, Zoetis
Vice-chairman Gaynor Hillier, Novartis
Vice-chairman Mrs Catherine Sayer, Forum
Vice chairman Mrs Mary Boughton, Dorwest Herbs